DE3486150D1 - Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. - Google Patents

Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.

Info

Publication number
DE3486150D1
DE3486150D1 DE8484307226T DE3486150T DE3486150D1 DE 3486150 D1 DE3486150 D1 DE 3486150D1 DE 8484307226 T DE8484307226 T DE 8484307226T DE 3486150 T DE3486150 T DE 3486150T DE 3486150 D1 DE3486150 D1 DE 3486150D1
Authority
DE
Germany
Prior art keywords
sup
osteitis
osteomyelitis
compositions
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE8484307226T
Other languages
English (en)
Other versions
DE3486150T2 (de
Inventor
Rolf Wilhelm Pfirrmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ed Geistlich Soehne AG fuer Chemische Industrie
Original Assignee
Ed Geistlich Soehne AG fuer Chemische Industrie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ed Geistlich Soehne AG fuer Chemische Industrie filed Critical Ed Geistlich Soehne AG fuer Chemische Industrie
Application granted granted Critical
Publication of DE3486150D1 publication Critical patent/DE3486150D1/de
Publication of DE3486150T2 publication Critical patent/DE3486150T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/15—Six-membered rings
    • C07D285/16—Thiadiazines; Hydrogenated thiadiazines
    • C07D285/18—1,2,4-Thiadiazines; Hydrogenated 1,2,4-thiadiazines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Saccharide Compounds (AREA)
DE84307226T 1983-10-20 1984-10-19 Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis. Expired - Fee Related DE3486150T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB838328073A GB8328073D0 (en) 1983-10-20 1983-10-20 Chemical compounds

Publications (2)

Publication Number Publication Date
DE3486150D1 true DE3486150D1 (de) 1993-07-01
DE3486150T2 DE3486150T2 (de) 1993-11-04

Family

ID=10550497

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19843438470 Withdrawn DE3438470A1 (de) 1983-10-20 1984-10-19 Mittel zur prophylaktischen behandlung von osteitis und osteomyelitis
DE84307226T Expired - Fee Related DE3486150T2 (de) 1983-10-20 1984-10-19 Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE19843438470 Withdrawn DE3438470A1 (de) 1983-10-20 1984-10-19 Mittel zur prophylaktischen behandlung von osteitis und osteomyelitis

Country Status (10)

Country Link
US (1) US4604391A (de)
EP (1) EP0139534B1 (de)
JP (1) JPS60105617A (de)
AT (1) ATE89731T1 (de)
AU (1) AU3457484A (de)
BE (1) BE900855A (de)
CH (1) CH660969A5 (de)
DE (2) DE3438470A1 (de)
GB (1) GB8328073D0 (de)
IT (1) IT1178155B (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3506288A1 (de) * 1984-09-06 1986-03-13 Johannes 7900 Ulm Reinmüller Vorrichtung zum einlegen in wunden und wundhoehlen
GB8424518D0 (en) * 1984-09-28 1984-11-07 Geistlich Sohne Af Fur Chemisc Chemical compounds
GB8827986D0 (en) * 1988-11-30 1989-01-05 Geistlich Soehne Ag Chemical product
US5819748A (en) * 1988-11-30 1998-10-13 Ed Geistlich Sohne Ag Fur Chemische Industrie Implant for use in bone surgery
GB9015108D0 (en) * 1990-07-09 1990-08-29 Geistlich Soehne Ag Chemical compositions
GB9216155D0 (en) * 1992-07-30 1992-09-09 Geistlich Soehne Ag Treatment of dentoalveolar infections
US6488912B1 (en) 1992-07-30 2002-12-03 Ed. Geistlich Soehne Ag Fuer Chemische Industrie Treatment of dentoalveolar infections with taurolidine and/or taurultam
DE19708782C1 (de) * 1997-03-04 1998-08-06 Claus Prof Dr Herdeis Verfahren zur Herstellung von 2-Aminoethansulfonylazid-säureadditionssalzen, 2-Aminoethansulfonylazid-hydrochlorid sowie dessen Verwendung
US6011030A (en) * 1997-09-22 2000-01-04 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating symptoms of microbial infection or sepsis
US5972933A (en) * 1998-01-08 1999-10-26 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of treating microbial infections
US6166007A (en) 1998-07-02 2000-12-26 Sodemann; Klaus Antimicrobial locks comprising taurinamide derivatives and carboxylic acids and/or salts thereof
US6350742B1 (en) * 1998-09-11 2002-02-26 Carter-Wallace, Inc. Compositions and methods for treating infections of the ear
CN100519525C (zh) * 1999-12-06 2009-07-29 葛兰素集团有限公司 芳香砜类及其医疗用途
CA2393159C (en) * 1999-12-06 2010-04-20 Paul Calabresi Methods of treating tumors
US20020004502A1 (en) * 2000-01-05 2002-01-10 Redmond H. Paul Treatment of inflammatory bowel disease
EP1450814B1 (de) 2001-10-01 2016-11-30 Geistlich Pharma AG Verfahren zur hemmung von metastasen
US20050008684A1 (en) * 2003-07-10 2005-01-13 Claus Herdeis Method of treatment for acne, rosacea and ulcers with taurolidine and/or taurultam in a pharmaceutical composition
US7696182B2 (en) 2004-11-02 2010-04-13 Nd Partners, Llc Antimicrobial locking solutions comprising taurinamide derivatives and biologically acceptable salts and acids, with the addition of small concentrations of heparin
DE07825069T1 (de) * 2006-09-07 2010-04-08 Ed Geistlich Söhne Ag Für Chemische Industrie Verfahren zur behandlung von knochenkrebs
CA3086396A1 (en) 2017-12-21 2019-06-27 Cormedix Inc. Methods and pharmaceutical compositions for treating candida auris in blood
US11738120B1 (en) 2022-04-14 2023-08-29 Cormedix Inc. Synthesis of taurolidine, purity profiles and polymorphs

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1124285A (en) * 1964-10-06 1968-08-21 Geistlich Soehne Ag Novel perhydro-1,2,4-thiadiazine dioxides-(1,1), their preparation and compositionscontaining them
GB1557163A (en) * 1975-06-24 1979-12-05 Geistlich Soehne Ag Dental care preparations
GB1525296A (en) * 1975-08-04 1978-09-20 Geistlich Soehne Ag Antibacterial compositions
US4107305A (en) * 1975-08-04 1978-08-15 Ed. Geistlich Sohne A.G. Fur Chemische Industrie Treatment of endotoxaemia
US4337251A (en) * 1979-05-09 1982-06-29 Ed. Geistlich Sohne Ag Fur Chemische Industrie Method of avoiding and removing adhesions

Also Published As

Publication number Publication date
DE3486150T2 (de) 1993-11-04
CH660969A5 (de) 1987-06-30
IT1178155B (it) 1987-09-09
JPS60105617A (ja) 1985-06-11
BE900855A (fr) 1985-02-15
IT8449032A0 (it) 1984-10-18
IT8449032A1 (it) 1986-04-18
ATE89731T1 (de) 1993-06-15
EP0139534B1 (de) 1993-05-26
US4604391A (en) 1986-08-05
AU3457484A (en) 1985-05-09
DE3438470A1 (de) 1985-05-30
EP0139534A3 (en) 1985-10-23
EP0139534A2 (de) 1985-05-02
GB8328073D0 (en) 1983-11-23

Similar Documents

Publication Publication Date Title
DE3486150D1 (de) Zusammensetzungen zur propylaktischen behandlung von osteitis und osteomyelitis.
ATE59296T1 (de) Zusammensetzungen zur bekaempfung von toxaemia.
AU557898B2 (en) Aminoethoxybenzylalcohol derivatives
ATE110568T1 (de) Pharmazeutisches präparat zur behandlung des katarakts.
ES8600224A1 (es) Procedimiento de preparacion de nuevos derivados carbamiloxibenzoles
GR79147B (de)
ES543798A0 (es) Procedimiento de preparacion de nuevos derivados 4-hidroxi- -a-etil-benzoles
ATE64095T1 (de) Verwendung von imidazochinazolinen zur behandlung und verhinderung von nephritis.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee